Insight Molecular Diagnostics IMDX
NASDAQ IMDX
$4.27 -0.03 (-0.70%)
As of: Aug 27, 2026 · 3:59 PM EDT

Insight Molecular Diagnostics (IMDX) Tax Provisions (2020 - 2025)

Insight Molecular Diagnostics (IMDX) posted Tax Provisions of -$97000.0 for Q4 2021, up 94.59% sequentially from -$1.8 million in Q2 2021, and down 161.01% YoY from $159000.0 in Q4 2020.

Insight Molecular Diagnostics (IMDX) Tax Provisions (2020 - 2025) Analysis & Trends

Insight Molecular Diagnostics has reported Tax Provisions for 2 years, with the latest figure at -$97000.0 in Q4 2021.

  • Quarterly Tax Provisions fell 161.01% year-over-year to -$97000.0 in Q4 2021, while the trailing twelve-month figure through Sep 2024 was -$97000.0 (changed N/A YoY) and the FY2022 annual result came in at -$1.2 million, up 87.04% from the prior year.
  • Tax Provisions grew to -$97000.0 in Q4 2021 per IMDX's latest filing, from -$1.8 million in the prior quarter.
  • Over five years, Tax Provisions peaked at $1.1 million in Q1 2020 and troughed at -$7.6 million in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn 167.00 Mn
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn 208.00 Mn
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn -300,000.00
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn 69.00 Mn
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn 60.00 Mn
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn 78.81 Mn
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn 53.00 Mn
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn 56.50 Mn
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn 87.30 Mn
10 Insight Molecular Diagnostics 158.03 Mn 139.50 Mn 157,000.00 -

Historic Data

Download Data
DateValue
Dec 31, 2025 -10.55 Mn
Dec 31, 2024 -12.74 Mn
Dec 31, 2021 -97,000.00
Jun 30, 2021 -1.79 Mn
Mar 31, 2021 -7.56 Mn
Dec 31, 2020 159,000.00
Jun 30, 2020 -2.19 Mn
Mar 31, 2020 1.10 Mn